Intervention Protocol

You have free access to this content

Nonsteroidal anti-inflammatory drugs for neuropathic pain

  1. Ching-Chi Chi1,2,*,
  2. Shu-Hui Wang3,4,
  3. Liang Tseng Kuo5,
  4. R Andrew Moore6

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 23 DEC 2013

DOI: 10.1002/14651858.CD010902


How to Cite

Chi CC, Wang SH, Kuo LT, Moore RA. Nonsteroidal anti-inflammatory drugs for neuropathic pain (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD010902. DOI: 10.1002/14651858.CD010902.

Author Information

  1. 1

    Chang Gung Memorial Hospital, Department of Dermatology and Centre for Evidence-Based Medicine, Chiayi, Taiwan

  2. 2

    Chang Gung University, College of Medicine, Taoyuan, Taiwan

  3. 3

    Far Eastern Memorial Hospital, Department of Dermatology, New Taipei, Taiwan

  4. 4

    Oriental Institute of Technology, Department of Healthcare Administration, New Taipei, Taiwan

  5. 5

    Chang Gung Memorial Hospital, Chiayi, Department of Orthopaedic Surgery, Chiayi, Taiwan

  6. 6

    University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK

*Ching-Chi Chi, chingchi@cgmh.org.tw. chingchichi@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 DEC 2013

SEARCH

References

Additional references

Apkarian 2011
Berger 2002
  • Berger A, Sadosky A, Dukes E, Edelsberg J, Oster G. Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurology 2012;12:8. [ISBN: 10.1186/1471-2377-12-8]
Berger 2004
Berger 2009
Bouhassira 2008
Cochrane PaPaS Group 2012
  • Cochrane Pain, Palliative and Supportive Care Group. PaPaS author and referee guidance. http://papas.cochrane.org/papas-documents (accessed 22 January 2013).
Derry 2012
  • Derry S, Moore RA. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010111]
Derry 2013
Di Franco 2010
  • Di Franco M,  Iannuccelli C,  Atzeni F,  Cazzola M,  Salaffi F,  Valesini G,  et al. Pharmacological treatment of fibromyalgia. Clinical and Experimental Rheumatology 2010;28(6 Suppl 63):S110-6.
Dworkin 2008
Grosser 2011
  • Grosser T, Smyth E. Chapter 34. Anti-inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC editor(s). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York: McGraw-Hill, 2011:http://www.accessmedicine.com/content.aspx?aID=16670422 (accessed 3 May 2013).
Gustorff 2008
Hall 2008
Hasnie 2007
  • Hasnie FS,  Breuer J,  Parker S,  Wallace V,  Blackbeard J,  Lever I,  et al. Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 2007;144(4):1495-508.
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Jadad 1996
Jensen 2011
  • Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, et al. A new definition of neuropathic pain. Pain 2011; Vol. 152, issue 10:2204-5. [DOI: 10.1016/j.pain.2011.06.017]
Katusic 1991
  • Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984. Neuroepidemiology 1991;10(5-6):276-81.
Kawakami 2002
  • Kawakami M,  Matsumoto T,  Hashizume H,  Kuribayashi K,  Tamaki T. Epidural injection of cyclooxygenase-2 inhibitor attenuates pain-related behavior following application of nucleus pulposus to the nerve root in the rat. Journal of Orthopaedic Research 2002;20(2):376-81.
Khaliq 2007
Koopman 2009
L'Abbé 1987
Laine 2001
Liberati 2009
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of internal medicine 2009;151(4):W65-94. [DOI: 10.7326/0003-4819-151-4-200908180-00136]
Lunn 2009
McQuay 1998
  • McQuay H, Moore R. An evidence-based resource for pain relief. 1. Oxford University Press, 1998. [ISBN: 978-0192630483]
McQuay 2007
  • McQuay HJ, Smith LA, Moore RA. Chronic Pain. In: Stevens A, Raftery J, Mant J, Simpson S editor(s). Health Care Needs Assessment. 3rd Edition. Oxford: Radcliffe Publishing, 2007. [ISBN: 978-1-84619-063-6]
Moisset 2007
Moore 1998
Moore 2008
  • Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5]
Moore 2009a
Moore 2009b
  • Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374-9. [DOI: [10.1136/ard.2009.107805]]
Moore 2010a
Moore 2010b
  • Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374-9. [DOI: 10.1136/ard.2009.107805]
Moore 2010c
Moore 2010d
Moore 2011a
  • Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2]
Moore 2011b
  • Moore RA, Straube S, Paine J, Derry S, McQuay HJ. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011;152(5):982-9. [DOI: 10.1016/j.pain.2010.11.030]
Moore 2011c
Moore 2012a
Moore 2012b
Moore 2013a
  • Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice 2013 Mar 6. [Epub ahead of print]. [DOI: 10.1111/papr.12050]
Moore 2013b
Moore 2013c
O'Brien 2010
O'Connor 2009
Rappaport 1994
Review Manager 2013
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013.
Seidel 2013
Soni 2013
Straube 2008
Straube 2010
Sultan 2008
Torrance 2006
Tracey 2011
Treede 2008
Vo 2009
Vos 2012
  • Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2163-96. [DOI: 10.1016/S0140-6736(12)61729-2]